MECP2 and fragile X syndrome: Despite their etiological differences, the two share several clinical and pathophysiological phenotypes, which can be explained by the interplay and common targets between FMRP and MeCP2, the proteins in which mutations are causative for FXS and RTT, respectively [62,179].